Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses
Triglyceride (TG)-lowering LPL variants in combination with genetic LDL-C-lowering variants are associated with reduced risk of coronary artery disease (CAD). Genetic variation in the APOA5 gene encoding apolipoprotein A-V also strongly affects TG levels, but the potential clinical impact and underl...
Main Authors: | Boot, M. (Author), Christodoulides, C. (Author), Dollé, M.E.T (Author), Ibi, D. (Author), Jukema, J.W (Author), Karpe, F. (Author), Koivula, R. (Author), Neville, M.J (Author), Noordam, R. (Author), Rensen, P.C.N (Author), Rosendaal, F.R (Author), van Dijk, K.W (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Biochemistry and Molecular Biology Inc.
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides
by: G.M. Anantharamaiah, et al.
Published: (2007-09-01) -
Study on the influence of 7-β-hydroxy-γ-aryloxypropylxanthinyl-8-thioalkanic acid derivatives on the lipid metabolism in experiment
by: I. M. Bilai, et al.
Published: (2021-06-01) -
The effect of Metronidazole on reducing blood lipids: a systematic review and meta-analysis
by: Behzad Jafarinia, et al.
Published: (2016-04-01) -
Familial Combined Hyperlipidemia (FCH) Patients with High Triglyceride Levels Present with Worse Lipoprotein Function Than FCH Patients with Isolated Hypercholesterolemia
by: Núria Puig, et al.
Published: (2020-01-01) -
Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels
by: S.F.C. Vaessen, et al.
Published: (2009-05-01)